Table 5.
Endpoint | Cases | Events | Variables | p-value |
---|---|---|---|---|
OS | 225 | 18 | IGF1R | 0.010* |
pIGF1R | 0.330 | |||
SphK | 0.617 | |||
ER | 0.561 | |||
PR | 0.167 | |||
DFS | 219 | 18 | IGF1R | 0.880 |
pIGF1R | 0.622 | |||
SphK | 0.305 | |||
ER | 0.470 | |||
PR | 0.128 | |||
OS | 221 | 17 | IGF1R | 0.053(*) |
pIGF1R | 0.544 | |||
SphK | 0.607 | |||
ER | 0.608 | |||
PR | 0.143 | |||
HER2 | 0.000* | |||
DFS | 215 | 17 | IGF1R | 0.794 |
pIGF1R | 0.732 | |||
SphK | 0.429 | |||
ER | 0.866 | |||
PR | 0.254 | |||
HER2 | 0.007* |
Cases available in analysis
Method = Forward Stepwise (Likelihood Ratio)